Search Results
167 items found for "Network pharmacology"
- Illuminating Functional Selectivity and Allosterism at GPCRs.
His expertise is in molecular pharmacology and his research program focuses on the molecular and cellular
- Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
Proost , Mette M Rosenkilde Tags GPCR , allosteric modulation , chemokine , chemokine truncation , pharmacology
- Ep 98 with Dr. GPCR Team
As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and
- Ep 103 with Dr Kathleen Caron
Caron is also past Associate Editor at JCI and served as the inaugural Associate Editor at ACS-Pharmacology
- Ep 143 with Dr Davide Calebiro
Between 2009 and 2017, he was a Group Leader at the Institute of Pharmacology and Toxicology and Rudolf
- Ep 32 with Dr. Chris Tate
Subsequent work has focused on understanding the molecular basis of GPCR pharmacology through structure
- Chemokine Physiology in Cancer
expression of atypical receptors and non-GPCR binding partners that cumulatively influence discrete pharmacological
- GPCRs and fibroblast heterogeneity in fibroblast-associated diseases
signaling , fibroblast behavior , fibrotic diseases , functional heterogeneity , pathophysiology , pharmacological
- Ep 144 with Dr Aurélien Rizk
They emphasized the significance of mathematical models in systems biology and pharmacology and the challenges Mathematical Models in Systems Biology and Pharmacology Aurelien Rizk and Yamina discussed the importance and relevance of mathematical models in systems biology and pharmacology.
- Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
heterotrimeric G-proteins can also be activated via GPCR-independent mechanisms that remain untapped as pharmacological
- Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
Notably, genetic or pharmacological activation of GPR132 triggered the differentiation of human primary
- Ep 130 with Dr. Richard Premont
Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology
- Ep 131 with Dr. Richard Premont
Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology
- Ep 106 with Dr. Bruno Giros
including the CNRS silver medal, the FRM "Young Researcher" prize, the ISI “Highly Cited” and F-1000 in Pharmacology
- Ep 71 with Dr. Jean Martin Beaulieu
In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia
- Ep 132 with Dr. Richard Premont
Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology
- Ep 42 with Dr. Randy Hall
., is a Professor of Pharmacology and Chemical Biology in the Emory University School of Medicine.
- Ep 133 with Dr. Richard Premont
Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology
- Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
Using genetic modification and pharmacological strategies we demonstrate mechanistically that this ATP-driven
- "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways
Caron is also past Associate Editor at JCI and served as the inaugural Associate Editor at ACS-Pharmacology
- Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
the arrestin mediated GPCR functions (Nature communications, 2015, 2021, 2022; PNAS 2021, Molecular Pharmacology
- Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression through GPCR receptor Mthl10
to be enhanced by GBP, indicating that both cytokines are organized within a hierarchical regulatory network presence of GBP1, indicating that GBP2 is an upstream expressional regulator of a GBP1/GBP2 cytokine network GBP2 control immune responses as well as their own expression levels through a hierarchical cytokine network
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College Tall Department of Pharmacology, University of Michigan "" About Frank Kwarcinski "I am research faculty within the department of Pharmacology at the University of Michigan.
- Ep 45 with Dr Ralf Jockers
He was the director of the French network of GPCRs (GDR-3545), currently directs the International Research Network (IRN) i-GPCRnet of the CNRS, is chair of IUPHAR « Melatonin receptor » sub-committee, Editor-in-Chief
- Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
To investigate the role of conformational dynamics in the distinct pharmacological behaviors of CXCR4
- Interrogating Multiscale Receptors Functions in Space
In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia
- CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions
Pharmacological inhibition of the lipid synthesis pathway by statins is a therapeutic approach to control
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Javitch1,2 1Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University initially became interested in GPCR signal transduction during my graduate training in the Department of Pharmacology